Letter of Intent Deadline: April 15, 2025 @ 12:00 p.m. (noon) ET
Award Amount: $30,000 a year for up to two years
The PhRMA Foundation Predoctoral Fellowship in Drug Discovery provides support for promising students (U.S. and non-U.S. citizens) in advanced stages of training and thesis research in drug discovery research.
Program Goals
Drug discovery involves the innovative application and integration of multiple scientific disciplines to create efficacious, safe, and differentiated treatment options for patients. The PhRMA Foundation seeks to fund novel early-stage, drug discovery research with a clear potential for translation to humans. Proposals should focus on biological validation of potential drug targets, such as molecular targets, targetable pathways, or targetable systems.
Research areas could include, but are not limited to:
- Cellular and Molecular Biology
- Design and Generation of Pharmacological Tools
- In Vitro and/or In Vivo Pharmacology
- Protein Biochemistry
- Molecular Modelling
- Structural Biology and Computational Structural Biology
- Biomedical Imaging (e.g., cellular)
- Single Cell Analysis (e.g., CRISPR screens)
- Spatial Omics
- Artificial Intelligence (AI) and Computational Approaches
Projects that focus exclusively on single aspects such as identification of and development of assays for single targets, chemical probes, biomarkers, chemical library screening, or diagnostics will not be considered. Studies considered exploratory in nature should contain a rigor and reproducibility plan.
Proposals that involve AI approaches (i.e., data-driven ML/DL) should clearly document and reference the methodology, explain the data curation process (sources, quality, quantity), and discuss the wet lab validation process. Expected pitfalls and alternative strategies should be described as well.
For eligibility information and to apply, please see the InfoReady application link.